Reports that the U.S. Patent and Trademark Office has awarded Incyte Pharmaceuticals Inc. the patent for an expressed sequence tag (EST). Role played by EST to encode novel human kinases; Concerns expressed by Francis Collins, director of the U.S. National Human Genome Research Institute on the Incyte patent.